Medartis Aims for Leadership Position in Extremities
The company grew +25% in 2022 and took its U.S. business to the next level with the acquisition of Nextremity Solutions. Mar 09, 2022
Treace Mining Bunion Expertise for Further Innovation
The company grew nearly 65% in 2021 and believes its focus on bunion surgery will reveal further opportunities for clinical distinction. Mar 08, 2022
OrthoPediatrics Expects Significant Tailwinds in 2022
The company grew nearly 38% in 2021 and expects another strong year in 2022 on the strength of a growing surgeon base and new products. Mar 07, 2022
Conformis Hopes to Rekindle Product Sales in 2022
The company grew 45% in 2021 on the strength of non-recurring royalty payments, but product revenue remains well below pre-pandemic levels. Mar 04, 2022
ATEC Sets Sights on Decade of Supremacy
The company grew nearly 70% in 2021, making it one of the premier growth stories in medtech. ATEC is bullish on its future prospects. Mar 03, 2022
SI-BONE Investments Set to Pay Off in 2022
The company grew over 20% in 2021 and expects similar growth in 2022 due to its expanded portfolio and exclusive payor coverage. Mar 02, 2022
Vericel Plans for Decade of Growth
The company grew almost 19% in 2021 while playing plans to expand production capacity and expand MACI's indication to the ankle. Mar 01, 2022
Orthofix Views 2022 As Inflection Point for Growth
The company grew 1% over its 2019 total and sees this year as a bridge to consistent mid-single-digit growth in the future. Feb 28, 2022
Medtronic Begins Active Portfolio Management Phase
The company's spine business grew in the high single digits for FY 3Q22 as the company prepares to make overall portfolio changes. Feb 25, 2022
NuVasive Ready to Grow Beyond XLIF Roots
The company grew in the high single-digits in 2021 and is ready to expand into other areas of spine as it becomes a comprehensive player. Feb 24, 2022
